A genome-wide CRISPR screen identifies N-acetylglucosamine-1-phosphate transferase as a potential antiviral target for Ebola virus
Mike Flint(Centers for Disease Control and Prevention), Christina F. Spiropoulou(CDC Foundation)
Cited by 74
Related Papers
Ebola Virus Epidemiology, Transmission, and Evolution during Seven Months in Sierra Leone
|Cell|2015|335
Rift Valley Fever Virus Encephalitis Is Associated with an Ineffective Systemic Immune Response and Activated T Cell Infiltration into the CNS in an Immunocompetent Mouse Model
|PLoS neglected tropical diseases|2014|62
Single-dose mucosal replicon-particle vaccine protects against lethal Nipah virus infection up to 3 days after vaccination
|Science Advances|2023|32
A public, cross‐reactive glycoprotein epitope confounds Ebola virus serology
|Journal of Medical Virology|2024|3